Stock Screener App

Gratuito -

Installare

1.17

0.00% 0.00

Fate Therapeutics Inc (FATE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Fate Therapeutics Inc Azioni (FATE) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	21.37% 1.369	1.741	1.907	1.629	1.86
Operating Expenses	1.06% 36.09	36.48	38.88	42.91	63.61
Benefits Costs and Expenses	-109.22	-	-	39.25	54.01
Costs And Expenses	23.73% 45.13	36.48	38.88	39.25	54.01
Operating Income/Loss	0.04% -34.72	-34.73	-36.97	-41.28	-61.75
Income/Loss From Continuing Operations Before Tax	6,252% 110.59	1.741	-34.07	-37.62	-52.15
Income/Loss From Continuing Operations After Tax	0.38% -32.37	-32.25	-34.07	-37.62	-52.15
Net Income/Loss	0.38% -32.37	-32.25	-34.07	-37.62	-52.15
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.87% 0.1536	119.00	118.53	118.38	1.3797
Diluted Average Shares	99.87% 0.1536	119.00	118.53	118.38	1.3797
Basic Earnings Per Share	0.00% -0.27	-0.27	-0.29	-0.32	-0.45
Diluted Earnings Per Share	0.00% -0.27	-0.27	-0.29	-0.32	-0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters